Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
1.850
+0.020 (1.09%)
At close: Dec 24, 2024, 1:00 PM
1.840
-0.010 (-0.55%)
After-hours: Dec 24, 2024, 1:44 PM EST
Taysha Gene Therapies Employees
Taysha Gene Therapies had 52 employees as of December 31, 2023. The number of employees decreased by 13 or -20.00% compared to the previous year.
Employees
52
Change (1Y)
-13
Growth (1Y)
-20.00%
Revenue / Employee
$190,673
Profits / Employee
-$437,923
Market Cap
379.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 52 | -13 | -20.00% |
| Dec 31, 2022 | 65 | -113 | -63.48% |
| Dec 31, 2021 | 178 | 140 | 368.42% |
| Dec 31, 2020 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Enhabit | 10,800 |
| ZimVie | 2,600 |
| REGENXBIO | 344 |
| Sana Biotechnology | 328 |
| IGM Biosciences | 224 |
| Codexis | 174 |
| GH Research | 49 |
| Contineum Therapeutics | 31 |
TSHA News
- 19 days ago - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
- 6 weeks ago - Taysha Gene Therapies, Inc. (TSHA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress - GlobeNewsWire
- 2 months ago - Taysha Gene Therapies: Unjustified Sell-Off - Enough Cash Runway And Promising Rett Syndrome Data - Seeking Alpha
- 4 months ago - Taysha Gene Therapies, Inc. (TSHA) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire